(0.74%) 5 165.80 points
(0.34%) 38 809 points
(0.86%) 16 295 points
(0.26%) $78.31
(3.17%) $2.21
(1.13%) $2 334.70
(3.60%) $27.65
(0.04%) $965.70
(-0.08%) $0.928
(-0.46%) $10.82
(-0.16%) $0.796
(-0.13%) $91.34
3 days till quarter result
(bmo 2024-05-09)
Expected move: +/- 0.00%
-0.26% ¥ 1 166.00
Live Chart Being Loaded With Signals
WIN-Partners Co., Ltd., through its subsidiaries, distributes medical devices to medical institutions primarily in Japan. The company offers percutaneous transluminal coronary angioplasty balloon catheters, drug-eluting stents, and intravascular ultrasound catheters; pacemakers, implantable cardioverter defibrillators, cardiac resynchronization therapy defibrillators, and ablation catheters; and stent grafts, transcatheter heart valves, and mechanical heart valves...
Stats | |
---|---|
Tagesvolumen | 13 100.00 |
Durchschnittsvolumen | 50 229.00 |
Marktkapitalisierung | 33.31B |
EPS | ¥0 ( 2024-02-06 ) |
Nächstes Ertragsdatum | ( ¥0 ) 2024-05-09 |
Last Dividend | ¥14.00 ( 2023-03-30 ) |
Next Dividend | ¥0 ( N/A ) |
P/E | 19.61 |
ATR14 | ¥0.890 (0.08%) |
WIN-Partners Co., Ltd. Korrelation
10 Am meisten positiv korreliert |
---|
10 Am meisten negativ korreliert |
---|
Wussten Sie das?
Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).
Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.
WIN-Partners Co., Ltd. Finanzdaten
Annual | 2022 |
Umsatz: | ¥70.85B |
Bruttogewinn: | ¥8.66B (12.23 %) |
EPS: | ¥72.04 |
FY | 2022 |
Umsatz: | ¥70.85B |
Bruttogewinn: | ¥8.66B (12.23 %) |
EPS: | ¥72.04 |
FY | 2022 |
Umsatz: | ¥66.39B |
Bruttogewinn: | ¥8.52B (12.83 %) |
EPS: | ¥63.88 |
FY | 2021 |
Umsatz: | ¥62.12B |
Bruttogewinn: | ¥7.74B (12.47 %) |
EPS: | ¥53.66 |
Financial Reports:
No articles found.
WIN-Partners Co., Ltd. Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
¥0 (N/A) |
¥0 (N/A) |
¥14.00 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | ¥12.50 | 2011-03-29 |
Last Dividend | ¥14.00 | 2023-03-30 |
Next Dividend | ¥0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 14 | -- |
Total Paid Out | ¥255.00 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2.11 | -- |
Div. Sustainability Score | 5.79 | |
Div.Growth Potential Score | 3.99 | |
Div. Directional Score | 4.89 | -- |
Year | Amount | Yield |
---|
With a moderate Dividend Sustainability Score (DSS), the company may sustain its dividends, but continuous monitoring is advised for any financial shifts. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
7956.T | Ex Dividend Knight | 2023-12-28 | Semi-Annually | 0 | 0.00% | |
7187.T | Ex Dividend Knight | 2023-09-28 | Annually | 0 | 0.00% | |
6432.T | Ex Dividend Junior | 2024-02-28 | Annually | 0 | 0.00% | |
5411.T | Ex Dividend Junior | 2023-09-28 | Annually | 0 | 0.00% | |
4433.T | Ex Dividend Knight | 2023-08-30 | Semi-Annually | 0 | 0.00% | |
3612.T | Ex Dividend Junior | 2023-09-28 | Annually | 0 | 0.00% | |
2818.T | Ex Dividend Junior | 2024-03-28 | Annually | 0 | 0.00% | |
1446.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
9740.T | Ex Dividend Knight | 2024-02-28 | Semi-Annually | 0 | 0.00% | |
8795.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0228 | 1.500 | 9.54 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0381 | 1.200 | 8.73 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0758 | 1.500 | -0.268 | -0.403 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 1.905 | 0.800 | 5.48 | 4.38 | [1 - 3] |
quickRatioTTM | 1.697 | 0.800 | 4.72 | 3.78 | [0.8 - 2.5] |
cashRatioTTM | 0.825 | 1.500 | 6.53 | 9.79 | [0.2 - 2] |
debtRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 0.6] |
interestCoverageTTM | 196 918 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 13.65 | 2.00 | 5.45 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 13.65 | 2.00 | 3.17 | 6.35 | [0 - 20] |
debtEquityRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 2.5] |
grossProfitMarginTTM | 0.123 | 1.000 | -1.278 | -1.278 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0318 | 1.000 | -1.365 | -1.365 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0 | 1.000 | -1.111 | -1.111 | [0.2 - 2] |
assetTurnoverTTM | 1.674 | 0.800 | 2.17 | 1.737 | [0.5 - 2] |
Total Score | 5.79 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 19.66 | 1.000 | 8.12 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0758 | 2.50 | -0.173 | -0.403 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 13.65 | 2.00 | 5.45 | 6.35 | [0 - 30] |
dividendYielPercentageTTM | 4.29 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 13.65 | 2.00 | 5.45 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 1.539 | 1.500 | 3.07 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.00524 | 1.000 | -2.37 | 0 | [0.1 - 0.5] |
Total Score | 3.99 |
WIN-Partners Co., Ltd.
WIN-Partners Co., Ltd., through its subsidiaries, distributes medical devices to medical institutions primarily in Japan. The company offers percutaneous transluminal coronary angioplasty balloon catheters, drug-eluting stents, and intravascular ultrasound catheters; pacemakers, implantable cardioverter defibrillators, cardiac resynchronization therapy defibrillators, and ablation catheters; and stent grafts, transcatheter heart valves, and mechanical heart valves. It also provides peripheral vascular stents, carotid artery stents, and embolic coils; and insulin pumps, as well as continuous glucose monitoring and magnetic resonance imaging equipment. The company was founded in 1973 and is headquartered in Tokyo, Japan.
Über Live-Signale
Die Live-Signale auf dieser Seite helfen dabei zu bestimmen, wann man NA kaufen oder verkaufen soll. Die Signale haben eine Verzögerung von bis zu 1 Minute; wie bei allen Marktsignalen besteht die Möglichkeit von Fehlern oder Fehleinschätzungen.
Die Live-Handelssignale sind nicht endgültig und getagraph.com übernimmt keine Verantwortung für Maßnahmen, die aufgrund dieser Signale ergriffen werden, wie in den Nutzungsbedingungen beschrieben. Die Signale basieren auf einer breiten Palette von technischen Analyseindikatoren.